Mainz Biomed NV (MYNZ)
(Delayed Data from NSDQ)
$1.43 USD
-0.02 (-1.38%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $1.43 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Mainz Biomed NV has a market cap of $6.64M, which represents its share price of $1.45 multiplied by its outstanding shares number of 4.58M. As a small-cap company, MYNZ's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MYNZ 1.43 -0.02(-1.38%)
Will MYNZ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MYNZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MYNZ
Monte Rosa Therapeutics (GLUE) Q4 Earnings and Revenues Top Estimates
Immunome, Inc. (IMNM) Reports Q4 Loss, Misses Revenue Estimates
MYNZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates
Absci Corporation (ABSI) Reports Q2 Loss, Lags Revenue Estimates
Fortress Biotech (FBIO) Reports Q2 Loss, Lags Revenue Estimates
Other News for MYNZ
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and ...
12 Health Care Stocks Moving In Friday's Intraday Session
Mainz Biomed (MYNZ) Announces Sale of 1.47 Million Ordinary Units
Mainz Biomed files to sell 1.47M ordinary units
Mainz Biomed files to sell 1.47M ordinary units